Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial
Baoqi Yang, Yuzhen Li, Yu Wang, Liuyi Yang et autres
0 citationsBritish Journal of Dermatology
Jianzhong Zhang
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
97Publications signalées
742Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Dermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisClimate Change and Health ImpactsAllergic Rhinitis and SensitizationAsthma and respiratory diseases
Publications récentes
52‐week ivarmacitinib in moderate‐to‐severe atopic dermatitis: A phase 3 trial
Yan Zhao, Melinda Gooderham, Bin Yang, Jiyuan Wu et autres
0 citationsJournal of the European Academy of Dermatology and Venereology
Efficacy and Safety of Anti‐IL‐4Rα Stapokibart in Elderly Patients With Moderate‐To‐Severe Atopic Dermatitis
Yan Zha, Litao Zhang, Liming Wu, Bin Yang et autres
1 citationInternational Journal of Dermatology
Efficacy and Safety of Stapokibart in Adults With Moderate‐to‐Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 Trial
Yan Zha, Litao Zhang, Liming Wu, Bin Yang et autres
2 citationsClinical and Translational Allergy
Efficacy of Biologics for the Treatment of Moderate‐To‐Severe Plaque Psoriasis in the Asian Population: A Systematic Review and Network Meta‐Analysis
Akihiko Asahina, Mir Sohail Fazeli, Robyn Kendall, Gopika Balasubramanian et autres
2 citationsInternational Journal of Dermatology
The ChinaSTAD Chinese Registry in Patients with Moderate-To-Severe Atopic Dermatitis Not Controlled by Topical Therapy: Baseline Characteristics, Disease Burden and Treatment
Ping Liu, Bingjiang Lin, Yanna Shen, Yonghong Lu et autres
0 citationsDermatology and Therapy
Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up
Jianzhong Zhang, Li He, Chen Xue, Ying Tu et autres
2 citationsDermatology and Therapy
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis
Yan Zhao, Cheng Zhou, Xiao‐Yong Man, Bing Liu et autres
4 citationsDermatitis
Regional and local burden of psoriasis in China, 1990–2021: Findings from the Global Burden of Disease Study 2021
Haihui Yang, Bin Yang, Pengpeng Ye, Hung Chak Ho et autres
3 citationsChinese Medical Journal
Can targeted industrial policy drive low-carbon transformation? evidence from China’s Five-Year Plans
Song Li, Jiali Yuan, Ting Li, Jianzhong Zhang
6 citationsFrontiers in Environmental Science
Long-Term Stapokibart Treatment Induces Sustained Clinical Improvements in Patients With Moderate-to-Severe Atopic Dermatitis
Yan Zhao, Litao Zhang, Liming Wu, Bin Yang et autres
1 citationDermatitis
A real-world study of ixekizumab use patterns, switching and efficacy in patients with plaque psoriasis
Zheng Zhao, Zhanglei Mu, Yan Zhao, Jianzhong Zhang et autres
1 citationArchives of Dermatological Research
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.